Clinical Trials List
2023-12-01 - 2026-12-31
Phase I/II
Recruiting3
ICD-10N52.01
Erectile dysfunction due to arterial insufficiency
ICD-10N52.02
Corporo-venous occlusive erectile dysfunction
ICD-10N52.03
Combined arterial insufficiency and corporo-venous occlusive erectile dysfunction
ICD-10N52.1
Erectile dysfunction due to diseases classified elsewhere
ICD-10N52.2
Drug-induced erectile dysfunction
ICD-10N52.31
Erectile dysfunction following radical prostatectomy
ICD-10N52.32
Erectile dysfunction following radical cystectomy
ICD-10N52.33
Erectile dysfunction following urethral surgery
ICD-10N52.34
Erectile dysfunction following simple prostatectomy
ICD-10N52.39
Other post-surgical erectile dysfunction
ICD-10N52.8
Other male erectile dysfunction
ICD-10N52.9
Male erectile dysfunction, unspecified
ICD-9607.84
Impotence of organic origin
xxxxxx
-
Trial Applicant
A2 HEALTHCARE TAIWAN CORPORATION
-
Sponsor
xxxxxx
-
Trial scale
Taiwan Multiple Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- SHAUH-DER YEH Division of Urology
- MING-CHE LIU Division of Urology
- CHIEN-CHIH WU Division of Urology
- 盧星華 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shian-Shiang Wang Division of Urology
- Jian-Ri Li Division of Urology
- Cheng-Che Chen Division of Urology
- Cheng-Kuang Yang Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
0 participants
